Duygu Bayır Garbioğlu

6PUBLICATIONS
44CO-AUTHORS
Liquid biopsiesPredictive and prognostic markersInnate immunityCancer diagnosisCancer genetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|May 08, 2026
Comparison of flat-dose versus weight-based dose nivolumab treatment in NSCLC patients.

|Apr 14, 2026
Baseline vitamin D status and clinical outcomes in advanced non-small cell lung cancer patients treated with nivolumab.

Gözde Ağdaş, Duygu Bayir, Elif Şahin

|Feb 21, 2026
The prognostic significance of early changes in the lung immune prognostic index in patients treated with immunotherapy for advanced-stage lung cancer.

Muhammet Cengiz, Oktay Bozkurt, Ayşe Nuransoy Cengiz

|Jan 28, 2026
Prognostic Significance of C-PLAN Index in Patients Treated with Immunotherapy for Non-Small-Cell Lung Cancer.

Ayse Nuransoy Cengiz, Oktay Bozkurt, Muhammet Cengiz

|Dec 25, 2025
A different variant of economic exploitation in oncology practice: medical board applications in Türkiye.

Arif Garbioğlu, Duygu Bayır Garbioğlu

|Aug 17, 2021
Determination of therapeutic agents efficiencies of microsatellite instability high colon cancer cells in post-metastatic liver biochip modeling.

Duygu Bayir Garbioglu, Nazan Demir, Ceren Ozel

Pageof 1

Frequent Collaborators

4 joint publications

Devrim Cabuk

4 joint publications

Deniz Can Guven

4 joint publications

Nargiz Majidova

4 joint publications

Emel Mutlu Ozkan